Annual Working Capital
$30.86 M
-$28.75 M-48.23%
31 December 2023
Summary:
Oncternal Therapeutics annual working capital is currently $30.86 million, with the most recent change of -$28.75 million (-48.23%) on 31 December 2023. During the last 3 years, it has fallen by -$81.28 million (-72.48%). ONCT annual working capital is now -76.78% below its all-time high of $132.93 million, reached on 31 December 2007.ONCT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$8.99 M
-$6.21 M-40.84%
30 September 2024
Summary:
Oncternal Therapeutics quarterly working capital is currently $8.99 million, with the most recent change of -$6.21 million (-40.84%) on 30 September 2024. Over the past year, it has dropped by -$28.35 million (-75.91%). ONCT quarterly working capital is now -93.23% below its all-time high of $132.93 million, reached on 31 December 2007.ONCT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.2% | -75.9% |
| 3 y3 years | -72.5% | -90.4% |
| 5 y5 years | +18.7% | -48.0% |
ONCT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.5% | at low | -90.4% | at low |
| 5 y | 5 years | -72.5% | +129.5% | -92.0% | at low |
| alltime | all time | -76.8% | +1697.4% | -93.2% | +128.2% |
Oncternal Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.99 M(-40.8%) |
| June 2024 | - | $15.20 M(-32.1%) |
| Mar 2024 | - | $22.39 M(-27.5%) |
| Dec 2023 | $30.86 M(-48.2%) | $30.86 M(-17.4%) |
| Sept 2023 | - | $37.34 M(-17.5%) |
| June 2023 | - | $45.24 M(-13.7%) |
| Mar 2023 | - | $52.43 M(-12.0%) |
| Dec 2022 | $59.61 M(-31.8%) | $59.61 M(-11.3%) |
| Sept 2022 | - | $67.16 M(-8.6%) |
| June 2022 | - | $73.47 M(-7.9%) |
| Mar 2022 | - | $79.77 M(-8.7%) |
| Dec 2021 | $87.39 M(-22.1%) | $87.39 M(-6.7%) |
| Sept 2021 | - | $93.70 M(-7.9%) |
| June 2021 | - | $101.70 M(-5.3%) |
| Mar 2021 | - | $107.36 M(-4.3%) |
| Dec 2020 | $112.14 M(+734.0%) | $112.14 M(+639.9%) |
| Sept 2020 | - | $15.16 M(+68.1%) |
| June 2020 | - | $9.02 M(-2.5%) |
| Mar 2020 | - | $9.25 M(-31.2%) |
| Dec 2019 | $13.45 M(-48.3%) | $13.45 M(-22.2%) |
| Sept 2019 | - | $17.29 M(-21.5%) |
| June 2019 | - | $22.03 M(+6.3%) |
| Mar 2019 | - | $20.71 M(-20.3%) |
| Dec 2018 | $26.00 M(-31.8%) | $26.00 M(-15.7%) |
| Sept 2018 | - | $30.84 M(-22.3%) |
| June 2018 | - | $39.70 M(+61.4%) |
| Mar 2018 | - | $24.60 M(-35.4%) |
| Dec 2017 | $38.10 M(+93.5%) | $38.10 M(-17.9%) |
| Sept 2017 | - | $46.40 M(+459.0%) |
| June 2017 | - | $8.30 M(-40.7%) |
| Mar 2017 | - | $13.99 M(-28.9%) |
| Dec 2016 | $19.69 M(+1046.6%) | $19.69 M(+61.8%) |
| Sept 2016 | - | $12.17 M(-33.5%) |
| June 2016 | - | $18.31 M(-22.2%) |
| Mar 2016 | - | $23.54 M(+1270.9%) |
| Dec 2015 | $1.72 M(-90.1%) | $1.72 M(-50.3%) |
| Sept 2015 | - | $3.45 M(-110.8%) |
| June 2015 | - | -$31.88 M(-306.0%) |
| Mar 2015 | - | $15.48 M(-10.8%) |
| Dec 2014 | $17.36 M | $17.36 M(+71.1%) |
| Sept 2014 | - | $10.14 M(-31.2%) |
| June 2014 | - | $14.75 M(-39.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $24.54 M(+131.4%) |
| Dec 2013 | $10.60 M(-77.6%) | $10.60 M(-36.2%) |
| Sept 2013 | - | $16.62 M(-31.7%) |
| June 2013 | - | $24.34 M(-31.3%) |
| Mar 2013 | - | $35.45 M(-25.1%) |
| Dec 2012 | $47.32 M(-33.4%) | $47.32 M(-21.0%) |
| Sept 2012 | - | $59.87 M(+17.4%) |
| June 2012 | - | $50.97 M(-16.3%) |
| Mar 2012 | - | $60.91 M(-14.2%) |
| Dec 2011 | $71.02 M(+29.0%) | $71.02 M(-11.4%) |
| Sept 2011 | - | $80.15 M(-9.1%) |
| June 2011 | - | $88.18 M(+81.3%) |
| Mar 2011 | - | $48.64 M(-11.7%) |
| Dec 2010 | $55.05 M(+58.6%) | $55.05 M(+157.7%) |
| Sept 2010 | - | $21.36 M(-25.9%) |
| June 2010 | - | $28.84 M(-21.2%) |
| Mar 2010 | - | $36.60 M(+5.4%) |
| Dec 2009 | $34.72 M(-56.1%) | $34.72 M(-11.3%) |
| Sept 2009 | - | $39.16 M(-27.1%) |
| June 2009 | - | $53.72 M(-19.1%) |
| Mar 2009 | - | $66.36 M(-16.0%) |
| Dec 2008 | $79.05 M(-40.5%) | $79.05 M(-11.6%) |
| Sept 2008 | - | $89.45 M(-12.4%) |
| June 2008 | - | $102.08 M(-13.4%) |
| Mar 2008 | - | $117.89 M(-11.3%) |
| Dec 2007 | $132.93 M(+19.4%) | $132.93 M(+61.4%) |
| Sept 2007 | - | $82.37 M(-11.0%) |
| June 2007 | - | $92.53 M(-10.0%) |
| Mar 2007 | - | $102.84 M(-7.6%) |
| Dec 2006 | $111.36 M(+59.0%) | $111.36 M(+80.7%) |
| Sept 2006 | - | $61.62 M(+21.9%) |
| June 2006 | - | $50.56 M(-16.1%) |
| Mar 2006 | - | $60.25 M(-14.0%) |
| Dec 2005 | $70.03 M(+14.2%) | $70.03 M(+121.6%) |
| Sept 2005 | - | $31.60 M(-23.1%) |
| June 2005 | - | $41.09 M(-20.8%) |
| Mar 2005 | - | $51.90 M(-15.3%) |
| Dec 2004 | $61.30 M(+379.8%) | $61.30 M(-16.4%) |
| Sept 2004 | - | $73.34 M(-6.9%) |
| June 2004 | - | $78.81 M(-6.6%) |
| Mar 2004 | - | $84.35 M(+560.3%) |
| Dec 2003 | $12.78 M(+66.9%) | $12.78 M |
| Dec 2002 | $7.65 M | - |
FAQ
- What is Oncternal Therapeutics annual working capital?
- What is the all time high annual working capital for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual working capital year-on-year change?
- What is Oncternal Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly working capital year-on-year change?
What is Oncternal Therapeutics annual working capital?
The current annual working capital of ONCT is $30.86 M
What is the all time high annual working capital for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual working capital is $132.93 M
What is Oncternal Therapeutics annual working capital year-on-year change?
Over the past year, ONCT annual working capital has changed by -$28.75 M (-48.23%)
What is Oncternal Therapeutics quarterly working capital?
The current quarterly working capital of ONCT is $8.99 M
What is the all time high quarterly working capital for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly working capital is $132.93 M
What is Oncternal Therapeutics quarterly working capital year-on-year change?
Over the past year, ONCT quarterly working capital has changed by -$28.35 M (-75.91%)